Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. 10595918

1999

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. 31091306

2019

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 PosttranslationalModification BEFREE A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study. 30249192

2018

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE AID-mediated genotoxic effects appear to occur frequently at the CDKN2b-CDKN2a locus and contribute to malignant transformation of the gastric mucosa. 20637757

2010

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Also suggested is that p16 has no role in the specific malignant transformation step from immortal premalignant lesions during the carcinogenesis of HPV-initiated cervical cancers. 9166931

1997

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Candidate markers of malignant transformation include p16, HMB45, and Ki-67, with p16 being of particular interest. 30887559

2019

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Deletions of RB1 and/or CDKN2A were observed in 71% of LGGs and in 90% of tumors after MT. 17308273

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE HMEC that express p16INK4A and vHMEC that do not, were transduced with constitutively active Ha-rasV12 and subsequently exposed to serum to determine whether signals from the cellular microenvironment could cooperate with ras to promote the malignant transformation of vHMEC. 19995452

2009

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE In mouse melanoma models with specific induced gene mutations including mutations of the Braf, Pten, and Cdkn2a genes, viral infection correlated with the extent of malignant transformation. 23552414

2013

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE In this report, we analyzed the methylation status of hMLH1 and p16 and the protein expression of PTEN and hMLH1 in 46 cases of endometriosis stages III and IV to better define the possible involvement of these genes in the malignant transformation of endometriosis. 12402310

2002

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. 17292825

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Inactivation of the p16(INK4a)/Rb pathway may allow continuous cell division and critical telomere shortening, which induce genome instability, finally leading to malignant transformation. 17428253

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE It has been shown that the induction of p16(Ink4a) in premalignant lesions and its loss during malignant transformation is an important mechanism in the carcinogenesis of several tumours. 21423154

2011

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE It has been suggested that the up-regulation of the tumour suppressor p16 gene and induction of senescence protect the phenotype of psoriatic involved skin from malignant transformation. 16552541

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE JunB is an essential upstream regulator of p16 and contributes to maintain cell senescence that blocks malignant transformation of TAC. 18628455

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation. 16687485

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 PosttranslationalModification BEFREE Methylation of the p16 gene may contribute to the malignant transformation of gastric precursor lesions. 15064707

2004

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE Methylation of the DAPK and p16 genes, although not sufficient to dictate prognosis of the disease, should not be underestimated because it may form part of a process of genetic and epigenetic alterations that in the future could become relevant to malignant transformation. 22371043

2012

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE Our study suggests that: (1) polysomy 6 and p16 deletion may contribute to adenomatous change of IPMN; (2) polysomy 7, polysomy 18, p16 deletion, and p53 deletion play roles in malignant transformation of noninvasive IPMN; and (3) polysomy 7 and p53 deletion may be excellent diagnostic markers for invasive IPMN. 25517961

2015

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 GeneticVariation BEFREE Results of this study suggest that two different genetic alterations, the inactivation of the p16 gene and genetic instability, play roles in the malignant transformation of carcinoma in pleomorphic adenoma. 9917133

1998

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Selective methylation was found in 19% for p16(INK4a), 36% for p15(INK4b), and 6.5% for both genes in MGUS, and frequencies were similar in MM suggesting that methylation of these genes is an early event, not associated with transition from MGUS to MM. p15(INK4b) and p16(INK4a) gene methylation might contribute to immortalization of plasma cells rather than malignant transformation in the natural history of MM. 11418489

2001

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE Since in our series just one out of eight anaplastic cases showed negative immunostaining and CDKN2A HD, p16/CDKN2A inactivation may not play an important role in the malignant transformation of ependymomas. 11763427

2001

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 Biomarker BEFREE Some bladder primary tumors and some bladder and melanoma tumor cell lines contain mutations in both P16 and P53 at frequencies that suggest that p53 and p16 function in different pathways, each of which is important in suppressing malignant transformation. 7747814

1995

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE Study on expression of p16 and human papillomavirus 16 and 18 (E6) in OLP and its malignant transformation. 29254790

2018

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.100 AlteredExpression BEFREE The aim of the study was to analyze the correlation between the expression of p16 as a surrogate of HPV infection in analyzed histopathological material and epidemiological variables, recurrences or malignant transformation. 28479047

2018